+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurointerventional Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 230 Pages
  • March 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6055902
The global neurointerventional device market is poised for significant expansion, driven by technological advancements and the increasing prevalence of neurological disorders. These devices play a crucial role in minimally invasive procedures aimed at treating conditions affecting the central nervous system. With rapid innovations in imaging modalities and treatment techniques, the market is witnessing notable transformations.

Market Insights

The neurointerventional device market is expected to maintain steady growth, reaching $28.42 billion by 2025 and further expanding to $39.26 billion by 2032, supported by a CAGR of 4.72%. The growing elderly population and heightened awareness of minimally invasive treatment options contribute to the rising demand for these devices.

The market is influenced by several key factors, including the integration of advanced imaging technologies and the development of highly specialized medical instruments such as catheters, stents, and embolic agents. These devices have significantly improved diagnostic accuracy and procedural effectiveness, making them a preferred choice in neurovascular treatments.

Market Growth Drivers

  • Technological Advancements: The integration of computed tomography (CT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA) enhances precision in neurointerventional procedures. Real-time, high-resolution imaging facilitates safer and more effective treatments.
  • Rising Incidence of Neurological Disorders: A growing number of stroke cases, aneurysms, and vascular malformations have led to increased demand for neurointerventional therapies.
  • Preference for Minimally Invasive Procedures: Healthcare providers and patients increasingly opt for neurointerventional techniques over traditional surgeries due to reduced recovery times and lower procedural risks.
  • Material Innovations in Devices: The development of biocompatible and flexible materials in catheters and stents has improved the safety and efficacy of procedures, reducing the risk of vessel injury.

Business Opportunities

  • Growing Geriatric Population: As aging populations are more susceptible to strokes and aneurysms, the demand for neurointerventional devices is rising.
  • Expanding Healthcare Infrastructure in Emerging Markets: Investments in healthcare development, particularly in Asia-Pacific and Latin America, are expected to drive demand for neurointerventional solutions.
  • Advancements in Bioabsorbable and Drug-Eluting Devices: The development of bioresorbable stents and embolic agents is anticipated to improve patient outcomes and expand the market.

Market Restraints

  • High Costs of Advanced Technologies: The high price of neurointerventional devices and associated procedures limits widespread adoption, particularly in low- and middle-income regions.
  • Complexity of Neurological Disorders: The diversity in patient cases and the intricate structure of the central nervous system require highly specialized and adaptable devices.

Regional Analysis

North America

  • Largest market share due to advanced healthcare infrastructure and high prevalence of neurological disorders.
  • Presence of key industry players and strong R&D investments contribute to market dominance.
  • Favorable reimbursement policies facilitate adoption of neurointerventional treatments.

Europe

  • Increasing adoption of neurointerventional technologies in Germany, France, and the UK.
  • Strong healthcare policies and government initiatives support market growth.

Asia-Pacific

  • Fastest-growing market, fueled by rising healthcare investments and improved access to advanced treatments.
  • Countries like China and India witness significant demand for minimally invasive procedures.
  • Growing awareness and government initiatives enhance market penetration.

Latin America & Middle East and Africa

  • Emerging markets benefiting from improving healthcare access.
  • Expansion of international manufacturers into these regions driving market development.

Key Players

The neurointerventional device market is led by major global players, including:

  • Medtronic
  • Stryker Corporation
  • Johnson & Johnson
  • Terumo Corporation
  • Penumbra Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
These companies focus on research and development, strategic acquisitions, and partnerships to strengthen their market presence. Notable acquisitions, such as Johnson & Johnson’s purchase of Codman Neuro and Stryker’s acquisition of the Neurovascular Division from Covidien, highlight ongoing efforts to enhance product portfolios.

Market Segmentation

By Product:

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Neurovascular Thrombectomy
  • Embolic Protection Device
  • Flow Diverters Device
  • Intrasaccular Device
  • Liquid Embolic
  • Balloons
  • Stent Retrievers

By Technique:

  • Neurothrombectomy Procedure
  • Cerebral Angiography
  • Stenting
  • Coiling Procedures
  • Flow Disruption

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Neurointerventional Device Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurointerventional Device Market Outlook, 2019 - 2032
3.1. Global Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Embolic Coils
3.1.1.2. Carotid Stents
3.1.1.3. Intracranial Stents
3.1.1.4. Neurovascular Thrombectomy
3.1.1.5. Embolic Protection Device
3.1.1.6. Flow Diverters Device
3.1.1.7. Intrasaccular Device
3.1.1.8. Liquid Embolic
3.1.1.9. Balloons
3.1.1.10. Stent Retrievers
3.2. Global Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Neurothrombectomy Procedure
3.2.1.2. Cerebral Angiography
3.2.1.3. Stenting
3.2.1.4. Coiling Procedures
3.2.1.5. Flow Disruption
3.3. Global Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Ambulatory Surgical Centers
3.4. Global Neurointerventional Device Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Neurointerventional Device Market Outlook, 2019 - 2032
4.1. North America Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Embolic Coils
4.1.1.2. Carotid Stents
4.1.1.3. Intracranial Stents
4.1.1.4. Neurovascular Thrombectomy
4.1.1.5. Embolic Protection Device
4.1.1.6. Flow Diverters Device
4.1.1.7. Intrasaccular Device
4.1.1.8. Liquid Embolic
4.1.1.9. Balloons
4.1.1.10. Stent Retrievers
4.2. North America Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Neurothrombectomy Procedure
4.2.1.2. Cerebral Angiography
4.2.1.3. Stenting
4.2.1.4. Coiling Procedures
4.2.1.5. Flow Disruption
4.3. North America Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centers
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Neurointerventional Device Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. U.S. Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
4.4.1.2. U.S. Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
4.4.1.3. U.S. Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
4.4.1.4. Canada Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
4.4.1.5. Canada Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
4.4.1.6. Canada Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurointerventional Device Market Outlook, 2019 - 2032
5.1. Europe Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Embolic Coils
5.1.1.2. Carotid Stents
5.1.1.3. Intracranial Stents
5.1.1.4. Neurovascular Thrombectomy
5.1.1.5. Embolic Protection Device
5.1.1.6. Flow Diverters Device
5.1.1.7. Intrasaccular Device
5.1.1.8. Liquid Embolic
5.1.1.9. Balloons
5.1.1.10. Stent Retrievers
5.2. Europe Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Neurothrombectomy Procedure
5.2.1.2. Cerebral Angiography
5.2.1.3. Stenting
5.2.1.4. Coiling Procedures
5.2.1.5. Flow Disruption
5.3. Europe Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centers
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Neurointerventional Device Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Germany Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.2. Germany Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.3. Germany Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.4. U.K. Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.5. U.K. Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.6. U.K. Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.7. France Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.8. France Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.9. France Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.10. Italy Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.11. Italy Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.12. Italy Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.13. Spain Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.14. Spain Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.15. Spain Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.16. Russia Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.17. Russia Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.18. Russia Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.19. Rest of Europe Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
5.4.1.20. Rest of Europe Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
5.4.1.21. Rest of Europe Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurointerventional Device Market Outlook, 2019 - 2032
6.1. Asia Pacific Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Embolic Coils
6.1.1.2. Carotid Stents
6.1.1.3. Intracranial Stents
6.1.1.4. Neurovascular Thrombectomy
6.1.1.5. Embolic Protection Device
6.1.1.6. Flow Diverters Device
6.1.1.7. Intrasaccular Device
6.1.1.8. Liquid Embolic
6.1.1.9. Balloons
6.1.1.10. Stent Retrievers
6.2. Asia Pacific Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Neurothrombectomy Procedure
6.2.1.2. Cerebral Angiography
6.2.1.3. Stenting
6.2.1.4. Coiling Procedures
6.2.1.5. Flow Disruption
6.3. Asia Pacific Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centers
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Neurointerventional Device Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. China Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.2. China Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.3. China Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.4. Japan Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.5. Japan Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.6. Japan Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.7. South Korea Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.8. South Korea Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.9. South Korea Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.10. India Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.11. India Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.12. India Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.13. Southeast Asia Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.14. Southeast Asia Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.15. Southeast Asia Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.16. Rest of Asia Pacific Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
6.4.1.17. Rest of Asia Pacific Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
6.4.1.18. Rest of Asia Pacific Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurointerventional Device Market Outlook, 2019 - 2032
7.1. Latin America Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Embolic Coils
7.1.1.2. Carotid Stents
7.1.1.3. Intracranial Stents
7.1.1.4. Neurovascular Thrombectomy
7.1.1.5. Embolic Protection Device
7.1.1.6. Flow Diverters Device
7.1.1.7. Intrasaccular Device
7.1.1.8. Liquid Embolic
7.1.1.9. Balloons
7.1.1.10. Stent Retrievers
7.2. Latin America Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
7.2.1.1. Neurothrombectomy Procedure
7.2.1.2. Cerebral Angiography
7.2.1.3. Stenting
7.2.1.4. Coiling Procedures
7.2.1.5. Flow Disruption
7.3. Latin America Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centers
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Neurointerventional Device Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Brazil Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
7.4.1.2. Brazil Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
7.4.1.3. Brazil Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.4. Mexico Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
7.4.1.5. Mexico Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
7.4.1.6. Mexico Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.7. Rest of Latin America Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
7.4.1.8. Rest of Latin America Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
7.4.1.9. Rest of Latin America Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurointerventional Device Market Outlook, 2019 - 2032
8.1. Middle East & Africa Neurointerventional Device Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Embolic Coils
8.1.1.2. Carotid Stents
8.1.1.3. Intracranial Stents
8.1.1.4. Neurovascular Thrombectomy
8.1.1.5. Embolic Protection Device
8.1.1.6. Flow Diverters Device
8.1.1.7. Intrasaccular Device
8.1.1.8. Liquid Embolic
8.1.1.9. Balloons
8.1.1.10. Stent Retrievers
8.2. Middle East & Africa Neurointerventional Device Market Outlook, by Technique, Value (US$ Bn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Neurothrombectomy Procedure
8.2.1.2. Cerebral Angiography
8.2.1.3. Stenting
8.2.1.4. Coiling Procedures
8.2.1.5. Flow Disruption
8.3. Middle East & Africa Neurointerventional Device Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centers
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Neurointerventional Device Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. GCC Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
8.4.1.2. GCC Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
8.4.1.3. GCC Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.4. South Africa Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
8.4.1.5. South Africa Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
8.4.1.6. South Africa Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.7. Rest of Middle East & Africa Neurointerventional Device Market by Product, Value (US$ Bn), 2019 - 2032
8.4.1.8. Rest of Middle East & Africa Neurointerventional Device Market by Technique, Value (US$ Bn), 2019 - 2032
8.4.1.9. Rest of Middle East & Africa Neurointerventional Device Market by End User, Value (US$ Bn), 2019 - 2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs by Technique Heat map
9.2. Manufacturer vs by Technique Heat map
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Abbott Laboratories
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Becton, Dickinson and Company (BD)
9.5.3. Bio-Rad Laboratories, Inc.
9.5.4. Danaher Corporation (Cepheid)
9.5.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
9.5.6. Hologic, Inc.
9.5.7. Laboratory Corporation of America Holdings
9.5.8. PerkinElmer, Inc.
9.5.9. Quest Diagnostics
9.5.10. Thermo Fisher Scientific, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...